Drug-coated balloons as the new standard of care for femoropopliteal in-stent restenosis: FAIR assumption?

Circulation

Volumn 132, Issue 23, 2015, Pages 2198-2200

  Laird, John R ^a   Singh, Gagan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Editorials; peripheral arterial disease; restenosis

Indexed keywords

PACLITAXEL;

ARTERY PROSTHESIS; ATHERECTOMY; CLINICAL EVALUATION; CRITICAL LIMB ISCHEMIA; DRUG ELUTING CARDIOVASCULAR STENT; DRUG ELUTING STENT; EDITORIAL; EQUIPMENT DESIGN; FEMOROPOPLITEAL BYPASS; FEMOROPOPLITEAL IN-STENT RESTENOSIS; FOLLOW UP; HEALTH CARE QUALITY; HEMODYNAMIC MONITORING; HUMAN; IN-STENT RESTENOSIS; LASER ATHERECTOMY; LOW LEVEL LASER THERAPY; MULTICENTER STUDY (TOPIC); PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; ADVERSE EFFECTS; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; MALE; PATHOLOGY; PROCEDURES; STENT;

ANGIOPLASTY, BALLOON; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; PACLITAXEL; STENTS;

EID: 84949422091     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.019462     Document Type: Editorial

References (20)

1. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010 3 267 276. doi: 10.1161/CIRCINTERVENTIONS.109.903468.
2. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007 115 2745 2749. doi: 10.1161/CIRCULATIONAHA.107.688341.
3. Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piorkowski M, Ulrich M, Bausback Y, Bräunlich S, Schmidt A, Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv 2013 6 65 71. doi: 10.1016/j.jcin.2012.09.011.
4. Laird JR, Katzen BT, Scheinert D, Paetzold A, Banning-Eichenseer U, Piorkowski M, Ulrich M, Bausback Y, Bräunlich S, Schmidt A, Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012 19 1 9
5. Armstrong EJ, Saeed H, Alvandi B, Singh S, Yeo KK, Anderson D, Westin GG, Dawson DL, Pevec WC, Laird JR, Nitinol stents versus balloon angioplasty for very long femoropopliteal lesions. J Endovasc Ther 2014 21 34 43
6. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M, Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012 59 16 23. doi: 10.1016/j.jacc.2011.09.036.
7. Armstrong EJ, Singh S, Singh GD, Yeo KK, Ludder S, Westin G, Anderson D, Dawson DL, Pevec WC, Laird JR, Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-Term outcomes after endovascular intervention. Catheter Cardiovasc Interv 2013 82 1168 1174
8. Schmidt A, Zeller T, Sievert H, Krankenberg H, Torsello G, Stark MA, Scheinert D, Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther 2014 21 52 60. doi: 10.1583/13-4538R.1.
9. Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C, EXCITE ISR Investigators Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv 2015 8 pt A 92 101. doi: 10.1016/j.jcin.2014.09.009.
10. Gorgani F, Telis A, Narakathu N, LaBarbera M, Babaev A, Long-Term outcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery. J Invasive Cardiol 2013 25 670 674
11. Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroë H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Peeters P, Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. J Endovasc Ther 2015 22 1 10. doi: 10.1177/1526602814564385.
12. Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A, Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv 2013 6 274 281. doi: 10.1016/j.jcin.2012.12.118.
13. Singh GD, Armstrong EJ, Laird JR, Femoropopliteal in-stent restenosis: current treatment strategies. J Cardiovasc Surg (Torino) 2014 55 325 333
14. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J, A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 2012 59 1377 1382. doi: 10.1016/j.jacc.2012.01.015.
15. Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J, Trial of paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 2015 373 145 153
16. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR, IN.PACT SFA Trial Investigators Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015 131 495 502. doi: 10.1161/CIRCULATIONAHA.114.011004.
17. Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Esposito G, Trimarco B, Rubino P, Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv 2014 7 411 415. doi: 10.1016/j.jcin.2013.11.020.
18. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L, Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther 2014 21 1 8. doi: 10.1583/13-4420R.1.
19. Krankenberg H, Tubler T, Ingwerson M, Schluter M, Scheinert D, Blessing E, Sixt S, Kieback A, Beschorner U, Zeller T, Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial. Circulation 2015 132 2230 2236. doi: 10.1161/CIRCULATIONAHA.115.017364.
20. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G, Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013 20 805 814. doi: 10.1583/13-4308MR.1.